The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices that works with employers to ensure their employees have access to high-quality, high-value, and local cancer care, announced today the addition of three new members to its Board of Directors.

The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices working to increase access to high-quality and local cancer care, announced today that it has partnered with XO Health to provide employers access to NCTA’s high-performing, high-value oncology network for their employees.

The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices that works with employers to ensure their employees have access to high-quality, high-value, and local cancer care, announced today that Kiana Mehring, MBA, of Florida Cancer Specialists and Research Institute (FCS), has joined the NCTA Board of Directors.

The National Cancer Treatment Alliance (NCTA) announced today five new member practices. NCTA now has 50 practices with 248 locations across 30 states.

The National Cancer Treatment Alliance (NCTA), a nationwide network of leading, independent community oncology practices that have joined together to help employers improve cancer care, announced today the appointment of two new board members, Mark Nelson, PharmD, Chief Executive Officer at Northwest Medical Specialties and Travis Brewer, Vice President of Payer and Public Health Strategy/Relations at Texas Oncology.

The National Cancer Treatment Alliance (NCTA) announced today the launch of a nationwide, clinically integrated network (CIN) of leading community oncology practices and pharmacies. Joining the CIN are 43 practices across 24 states. The organization seeks to partner with employers to reduce costs and ensure high-quality, patient-centered cancer care.

The National Cancer Treatment Alliance (NCTA), a nationwide coalition of leading oncology practices and pharmacies, announced the appointment of Stephen “Fred” Divers, MD, to its Board of Directors.